SRP4178
IL-17A from rat
recombinant, expressed in E. coli, ≥95% (SDS-PAGE), ≥95% (HPLC)
Sinonimo/i:
Ctla8, IL17, IL17a
Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
About This Item
Prodotti consigliati
Origine biologica
rat
Ricombinante
expressed in E. coli
Saggio
≥95% (HPLC)
≥95% (SDS-PAGE)
Forma fisica
lyophilized
Potenza
30 ng/mL
PM
~30 kDa
Confezionamento
pkg of 10 μg
Condizioni di stoccaggio
avoid repeated freeze/thaw cycles
Impurezze
endotoxin, tested
N° accesso NCBI
N° accesso UniProt
Condizioni di spedizione
wet ice
Temperatura di conservazione
−20°C
Informazioni sul gene
rat ... Il17a(25465)
Descrizione generale
IL-17A (interleukin 17A) is the first cytokine member of the family composed of IL-17A-F. These cytokines are mainly produced by activated CD4+ (cluster of differentiation) T cells. IL-17A is predominantly synthesized by T-helper (Th)-17 lymphocytes, γδ T cells (γδ-17), cytotoxic CD8+ T cells (Tc17), natural killer T (NKT) cells, and neutrophils.
Azioni biochim/fisiol
IL-17A (interleukin 17A) acts as a regulator of immune responses in inflammatory disorders, and acts as a potent pleiotropic proinflammatory cytokine where it promotes the release of other pro-inflammatory cytokines from a variety of cells. This cytokine is linked with pain, and IL-17A and IL-17A+ T cells are found in patients with arthritic pain, and in induced animal models of sciatic nerve, and optic nerve injury with neuropathic pain. This protein is thought to be involved in myocardial remodeling and fibrosis, where it promotes the synthesis of collagens and matrix metalloproteinases (MMPs) and activates cardiomyocyte apoptosis.
Recombinant rat IL-17 produced from Escherichia coli is a homodimeric, non-glycosylated polypeptide containing 268 amino acids and has a molecular weight of 30kDa.
Recombinant rat IL-17 produced from Escherichia coli is a homodimeric, non-glycosylated polypeptide containing 268 amino acids and has a molecular weight of 30kDa.
Stato fisico
Lyophilized (from 10 mM Sodium Citrate, pH 3.0).
Ricostituzione
Centrifuge the vial prior to opening. Avoid freeze-thaw cycles.
Reconstitute in water to a concentration of 0.1-1.0 μg/μL (Note: Gently pipetting to dissolve). The solution can then be diluted into other aqueous buffers.
Certificati d'analisi (COA)
Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.
Possiedi già questo prodotto?
I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.
Pengfei Ni et al.
Journal of neuroinflammation, 15(1), 332-332 (2018-12-07)
Perioperative neurocognitive disorders (PND) occur frequently after surgery, especially in aged patients. Surgery-induced neuroinflammation and blood-brain barrier (BBB) dysfunction play a crucial role in the pathogenesis of PND. Interleukin-17A (IL-17A) increases after surgical stress and will be involved in BBB
Interleukin-17A Exacerbates Ferric Chloride-Induced Arterial Thrombosis in Rat Carotid Artery.
Maione F et al
International Journal of Inflammation, 2014, 247503-247503 (2014)
Baraa Noueihed et al.
Frontiers in cell and developmental biology, 9, 630645-630645 (2021-02-09)
Ischemic retinopathies (IRs), such as retinopathy of prematurity and diabetic retinopathy, are characterized by an initial phase of microvascular degeneration that results in retinal ischemia, followed by exaggerated pathologic neovascularization (NV). Mesenchymal stromal cells (MSCs) have potent pro-angiogenic and anti-inflammatory
Wendy Dankers et al.
Arthritis research & therapy, 20(1), 212-212 (2018-09-22)
Despite recent improvements in the treatment of rheumatoid arthritis (RA), an insufficient treatment response and the development of treatment resistance in many patients illustrates the need for new therapeutic strategies. Chronic synovial inflammation could be suppressed by targeting RA synovial
Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
Mitsuaki Ishioka et al.
Digestive diseases and sciences, 62(2), 396-406 (2016-12-04)
Although several types of diet have been used in experimental steatohepatitis models, comparison of gut microbiota and immunological alterations in the gut among diets has not yet been performed. We attempted to clarify the difference in the gut environment between
Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..
Contatta l'Assistenza Tecnica.